Evidence map›Paper›PMID 24918617›Full record

ArticleTransplantation2014

The combined risk of donor quality and recipient age: higher-quality kidneys may not always improve patient and graft survival.

Roland A Hernandez, Sayeed K Malek, Edgar L Milford, Samuel R G Finlayson, Stefan G Tullius

Abstract read
In one paragraph

Article in Transplantation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Is the Kidney Donor Risk Index a Useful Tool in Non-US Patients?Canadian journal of kidney health and disease · 2018
    Article
  11. Review
  12. Waiting for a Deceased Kidney Donor Transplant: Better a Small Fish Than an Empty Dish?Clinical journal of the American Society of Nephrology : CJASN · 2016
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Roland A Hernandez1 Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA. 2 Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH. 3 Division of Transplant Surgery, Brigham and Women's Hospital, Boston, MA. 4 Division of Renal Medicine, Brigham and Women's Hospital, Boston, MA. 5 Department of Surgery, University of Utah School of Medicine, Salt Lake City, UT. 6 Address correspondence to: Stefan G. Tullius, M.D., Ph.D., Division of Transplant Surgery, Brigham and Women's Hospital, 75 Francis Street, PBB215, Boston, MA 02140.
Sayeed K Malek
Edgar L Milford
Samuel R G Finlayson
Stefan G Tullius

Funding

Consequences of Aging on Immune Response and Transplant OutcomeR01AG039449 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI TULLIUS, STEFAN GUNTHER · 2012 to 2016
$1.6M
NIA NIH HHS R01 AG039449NIA NIH HHS R01AG039449PHS HHS 234-2005-37011C.
6 · The paper itself

Abstract

backgroundThe Kidney Donor Profile Index (KDPI) is a more precise donor organ quality metric replacing age-based characterization of donor risk. Little prior attention has been paid on the outcomes of lower-quality kidneys transplanted into elderly recipients. Although we have previously shown that immunological risks associated with older organs are attenuated by advanced recipient age, it remains unknown whether risks associated with lower-quality KDPI organs are similarly reduced in older recipients.

methodsDonor organ quality as measured by the KDPI was divided into quintiles (very high, high, medium, low, and very low quality), and Cox proportional hazards was used to assess graft and recipient survival in first-time adult deceased donor transplant recipients by recipient age.

resultsIn uncensored graft survival analysis, recipients older than 69 years had demonstrated comparable outcomes if they received low-quality kidneys compared to medium-quality kidneys. Death-censored analysis demonstrated no increased relative risk when low-quality kidneys were transplanted into recipients aged 70 to 79 years (hazard ratio [HR], 1.11; P=0.19) or older than 79 years (HR, 1.08; P=0.59). In overall survival analysis, elderly recipients gained no relative benefit from medium-quality kidneys over low-quality kidneys (70-79 years: HR, 1.03, P=0.51; >79 years: HR, 1.08; P=0.32).

conclusionOur analysis demonstrates that transplanting medium-quality kidneys into elderly recipients does not provide significant advantage over low-quality kidneys.

Indexed as

Kidney TransplantationTissue DonorsAdolescentAdultAgedAged, 80 and overAge FactorsCohort StudiesFemaleGraft SurvivalHumansKidney Failure, ChronicMaleMiddle AgedRisk FactorsSurvival Analysis

Identifiers

PMID24918617
PMCPMC4455544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.